4//SEC Filing
Rosenberg Noah L. 4
Accession 0001209191-21-005253
CIK 0001438533other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 8:57 PM ET
Size
7.7 KB
Accession
0001209191-21-005253
Insider Transaction Report
Form 4
Rosenberg Noah L.
Chief Medical Officer
Transactions
- Award
Employee stock option (right to buy)
2021-01-21+57,500→ 57,500 totalExercise: $26.88Exp: 2031-01-20→ Common Stock (57,500 underlying) - Award
Common Stock
2021-01-21+15,000→ 42,720 total
Footnotes (3)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan that are scheduled to vest over four years.
- [F2]Includes 165 shares of the Issuer's common stock acquired by the reporting person on November 30, 2020 pursuant to an employee stock purchase program.
- [F3]One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001579649
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 8:57 PM ET
- Size
- 7.7 KB